Date:8/2/2012

Global, Revenue ($m), 2011 33Table 14: Planned Filings, Novartis, 2012 to ? 2016 33Table 15: Major Products, Sanofi, Global, Revenue ($m), 2011 39Table 16: Late-stage Pipeline, Sanofi, 2012 40Table 17: Major Products, GlaxoSmithKline, Global, Revenue ($m), 2011 44Table 18: Late-stage Pipeline, GlaxoSmithKline, 2012 44Table 19: Medical Device Market ($bn), Australia, 2006–2011 50Table 20: Medical Device Market ($bn), Australia, Forecast, 2011-2020 51Table 21: Medical Device Market, Australia, Segments, Revenue ($m), 2011 52Table 22: In Vitro Diagnostics Market ($m), Australia, 2006–2011 53Table 23: Sales Trends for Major Players*, In Vitro Diagnostics Devices, Australia, 2010 54Table 24: Orthopedic Devices Market ($m), Australia, 2006–2011 55Table 25: Sales Trends for Major Players*, Orthopedic Devices, Australia, 2010 56Table 26: Ophthalmic Devices Market ($m), Australia, 2006–2011 57Table 27: Sales Trends for Major Players*, Ophthalmic Devices, Australia, 2010 58Table 28: Diagnostic Imaging Market ($m), Australia, 2006–2011 59Table 29: Sales Trends for Major Players*, Diagnostic Imaging, Australia, 2010 60Table 30: Cardiovascular Devices Market ($m), Australia, 2006–2011 61Table 31: Sales Trends for Major Players*, Cardiovascular Devices, Australia, 2010 62Table 32: Major Products, Siemens, Global, Revenue ($m), 2010 63Table 33: Major Products, DePuy, 2012 70Table 34: Major Products, Roche, Global, Revenue ($m), 2010 73Table 35: Late-stage Pipeline, F. Hoffmann-La Roche Ltd., 2012 74Table 36: Major Products, Stryker, Global, Revenue ($m), 2010 77Table 37: Medicare Safety Net Original Threshold, Australia, 2012 85Table 38: Extended Medicare Safety Net Medicare Safety Threshold, Australia, 2012 85Table 39: Healthcare Spending, Australia, Patient's Share (%), 2005–2010 87Table 40: Change in Average Annual Price of Pharmaceutical Benefit Scheme Drugs (%), Australia, 2005–2010 88Table 41: Classification of Medical Devices,
'/>"/>

SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related biology technology :

1. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
2. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
3. ADVENTRX Announces Establishment of Regulatory Advisory Board
4. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
5. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
6. In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
7. Algae.Tec Announces Commencement of Australian Advanced Biofuels Facility Commissioning
8. Australian Discovered Biomarkers Map Path to New Blood Test for Bowel Cancer
9. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
10. Tom Karagiannis, Ph.D. Awarded Future Fellowship by Australian Research Council (ARC)